Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Warrants Presented at Fair Value

v3.22.1
Warrants Presented at Fair Value
 12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
WARRANTS PRESENTED AT FAIR VALUE
NOTE 12:- Warrants presented at fair value

 

The Company’s outstanding warrants classified as a liability as of December 31, 2020 are as follows:

 

Outstanding     Exercise
price		     Issuance
year		    

Exercisable

through

     Fair value      
                               
  120,000     $ 0.92 (*)     2014       (**** )   $ 2,002     (******)
  374,001       1.50       2016       2021       91     (******)
  905,555       0.17       2017       2022       108,090     Refer to Note 8.a.
  436,666       1.50       2017       2022       4,266     (******)
  33,332       1.20       2017       2022       485     Refer to Note 8.a.
  33,332       1.00       2017       2022       485     Refer to Note 8.a.
  675,926      
 (**
 )     2017       2022       155,839     (******)
  11,111       1.20       2017       2022       143     Refer to Note 11.b.1.
  1,659,971       0.17       2018       2022       199,083     Refer to Note 8.a.
  29,411,765       0.17       2018       2021 (*****)     2,598,037     Refer to Note 8.c.
  15,096,365      
 (***
 )      (*** )     (*** )     1,333,511     Refer to Note 8.c.
  1,411,765       0.17       2019       2024       204,242     Refer to Note 8.e.
  5,882,352       0.17       2019       2021       430,469     Refer to Note 8.f.
  18,382,352       0.17       2019       2021 (*****)     1,623,773     Refer to Note 8.c.
  13,970,587       0.17       2019       2021       1,334,255     Refer to Note 8.g.
  246,294       0.17       2020       2021 (*****)     21,756     Refer to Note 8.c.
  8,000,000     $ 0.26       2020       2022     $ 691,473     Refer to Note 3
                                         
  96,651,374                             $ 8,708,000     (*******)

 

(*) Subject to changes as describe in the agreement.

 

(**) Less than $0.01.

 

(***) Since the actual number of warrants cannot be determined as of December 31, 2020, the outstanding amounts were calculated based on an exercise price of $0.17, which results in the maximum potential amount of warrants.

 

(****) M&A or qualified PO as described in the agreement.

 

(*****) Two years from the registration statement or a PO, the earlier.

 

(******) Issued in connection with the 2014 through 2017 financing rounds.

 

(*******) Contains warrants presented at fair value within current liabilities of $7,343,894 and within non-current liabilities of $1,364,106.

 

The Company’s outstanding warrants classified as a liability as of December 31, 2019 are as follows:

 

Outstanding     Exercise price   Issuance year   Exercisable through   Fair value      
                         
  120,000     $
0.92(*)
   2014   (*****)   $ 6     (********)
  296,813       1.50   2015   2020    
-
     (********)
  374,001       1.50   2016   2021     2     (********)
  905,555       0.17   2017   2022     22,027     Refer to Note 8.a.
  333,333       1.50   2017   2022     96      
  53,333       1.50   2017   2022     2      
  50,000       1.50   2017   2022     3      
  33,332       1.20   2017   2022     16     Refer to Note 8.a.
  33,332       1.00   2017   2022     16     Refer to Note 8.a.
  675,926      
 (**)
   2017   2022     68,275      
  11,111       1.20   2017   2022     4     Refer to Note 11.b.1.
  300,000       0.50   2018   2023     1,560      
  1,659,971       0.17   2018   2022     11,522     Refer to Note 8.a.
  29,411,765      
0.17(***)
   2018   2021(******)     420,386     Refer to Note 8.c.
  15,441,177      
 (****)
    (****)   (****)     220,704     Refer to Note 8.c.
  6,617,647      
0.17(***)
   2018   2020(*******)     50,510      
  11,764,706      
0.17(***)
   2018   2020(*******)     107,602      
  1,411,765      
0.17(***)
   2019   2024   49,100     Refer to Note 8.e.
  5,882,352      
0.17(***)
   2019   2021(*******)     61,541     Refer to Note 8.f.
  18,382,352      
0.17(***)
   2019   2021(******)     262,742     Refer to Note 8.c.
  13,970,587     $
0.17(***)
   2019   2021(*******)   $ 227,998     Refer to Note 8.g.
                             
  107,729,058                 $ 1,504,112     (*********)

 

(*) Subject to changes as describe in the agreement.

 

(**) Less than $0.01.

 

(***) Subject to a mechanism described in the agreement but not less than $0.17, therefore, the outstanding amounts were calculated based on an exercise price of $0.17, which results in the maximum potential amount of warrants.

 

(****) Since the actual number of warrants cannot be determined as of December 31, 2019, the outstanding amounts were calculated based on an exercise price of $0.17, which results in the maximum potential amount of warrants.

 

(*****) M&A or qualified PO as described in the agreement.

 

(******) Two years from the registration statement or a PO, the earlier

 

(*******) Two years or a PO, the earlier.

 

(********) Issued in connection with the 2016, 2015 and 2014 financing rounds.

 

(*********)  Contains warrants presented at fair value within current liabilities of $158,112 and within non-current liabilities of $1,346,000.